retatrutide efficacy clinical trials and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide TRANSCEND-T2D-1 topline results are

The bottom line Your diet is important for many reasons

The 2024 joint scientific statement on nutrition and GLP-1 medications recommends involving a registered dietitian where appropriate, especially for people at risk of inadequate nutrient intake or muscle loss

Shelf-Stable Formula Vegan, non-GMO, gluten-free, dairy-free, and designed for stability without refrigeration

For a detailed head-to-head comparison, see our retatrutide vs tirzepatide comparison guide

Excessive alcohol use is a known risk factor for pancreatitis

At that point, the amount of drug leaving your body is balanced by the amount youre adding with each new dose, creating a reliable therapeutic effect